NCT03331458: PACMen

Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility Study

Completed NA Last updated 26 August 2019

What this trial tests

NA trial testing exrecise intervention in Prostate Cancer in 13 participants. Completed in 21 March 2019.

Timeline

17 April 2018

Primary endpoint
21 March 2019

21 March 2019

Quick facts

Lead sponsor	Duke University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	13
Start date	17 April 2018
Primary completion	21 March 2019
Estimated completion	21 March 2019
Sites	1 location across United States

Drugs / interventions tested

• exrecise intervention

Conditions studied

• Prostate Cancer — all drugs for Prostate Cancer →

Sponsor

Duke University

Who can join

18 and older, male only, with Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recent research has indicated that physical activities incorporating moderate-intensity exercise can be safely performed during treatment and substantially reduces treatment-related side effects, such as fatigue, sleep disturbances, cognitive impairment, and nausea. However, little is known about physical activity levels prior to treatment and whether providing an exercise intervention pre-treatment may improve functional capacity during treatment.

The purpose of this study is to

1. Measure physical activity levels and functional capacity in men newly diagnosed with prostate cancer prior to treatment and
2. Explore whether a 2-week physical activity intervention is feasible during the pre-treatment timeframe:

1. Examine intervention safety and tolerance by self-report
2. Examine changes in functional capacity by 6-minute walk test
3. Examine changes in symptom experience by self-report

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.